The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee
-
November 9, 2023
-
0 min
Clinical Scorecard: 49th Annual Conference of the European Society for Blood and Marrow Transplantation: Organizing Committee Overview
At a Glance
| Category | Detail |
|---|---|
| Condition | Blood and marrow transplantation and related hematologic conditions |
| Key Mechanisms | Multidisciplinary collaboration and scientific exchange in hematopoietic stem cell transplantation |
| Target Population | Patients requiring blood and marrow transplantation, including those with acute leukemia, aplastic anemia, autoimmune diseases, chronic malignancies, inborn errors, infectious diseases, lymphoma, and pediatric diseases |
| Care Setting | Specialized transplant centers and hematology departments across Europe and internationally |
Key Highlights
- The conference is a hybrid meeting held from 23–26 April 2023, sponsored by the European Society for Blood and Marrow Transplantation (EBMT).
- The Scientific Organising Committee comprises international experts from multiple countries, reflecting a broad multidisciplinary approach.
- The EBMT includes multiple working parties focusing on specific disease areas and transplant complications, promoting specialized research and clinical practice.
Guideline-Based Recommendations
Diagnosis
- Utilize multidisciplinary expertise from various working parties to guide diagnosis in hematologic and transplant-related conditions.
Management
- Implement evidence-based transplantation protocols developed and reviewed by EBMT working parties and committees.
- Engage in continuous education and research as facilitated by the EBMT Education portfolio.
Monitoring & Follow-up
- Monitor transplant outcomes and complications through EBMT Registry and Quality Management Group initiatives.
Risks
- Address transplant complications with guidance from the Transplant Complications Working Party.
- Consider infectious disease risks managed by the Infectious Diseases Working Party.
Patient & Prescribing Data
Patients undergoing hematopoietic stem cell transplantation for various hematologic diseases.
Treatment approaches are informed by specialized working parties and committees focusing on disease-specific and transplant-related issues.
Clinical Best Practices
- Foster collaboration among international experts to optimize transplantation outcomes.
- Engage multidisciplinary teams including nurses, pharmacists, and data management specialists for comprehensive care.
- Utilize registry data and quality management to continuously improve clinical protocols.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.